Cannabidiol in Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Icahn School of Medicine at Mount Sinai, Manhattan, New York, United States
Contact: Study coordinator (Susanna Curtis, MD, PhD) · susanna.curtis@mssm.edu
Contact: Principal Investigator (Susanna Curtis)

Study leads

Susanna Curtis
Principal Investigator
Icahn School of Medicine at Mount Sinai

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Sickle Cell Disease Vaso-occlusive Crisis

Abroad (travel likely)RecruitingPHASE2

Oakland, United States · Orange, United States

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Orange, United States

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Sickle Cell Disease

IsraelRecruitingPHASE3

Birmingham, United States · Phoenix, United States

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Sickle Cell Disease · Sickle Cell Anemia · Osteonecrosis

Abroad (travel likely)RecruitingPHASE2

Sacramento, United States